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Abstract.  A  characterization of the S.  cerevisiae 
KRE6 and SKN1 gene products extends previous 
genetic studies on their role in (1--'6)-/3-glucan  biosyn- 
thesis (Roemer, T., and H. Bussey.  1991. Yeast 
/3-glucan synthesis: KRE6 encodes a predicted type II 
membrane protein required for glucan synthesis in 
vivo and for glucan synthase activity in vitro. Proc. 
Natl.  Acad.  Sci.  USA.  88:11295-11299;  Roemer, T., S. 
Delaney, and H.  Bussey.  1993. SKN1  and KRE6 define 
a pair of functional homologs encoding putative mem- 
brane proteins involved in/3-glucan synthesis. Mol. 
Cell.  Biol.  13:4039-4048).  KRE6 and SKN1 are 
predicted to encode homologous proteins that partici- 
pate in assembly of the cell wall polymer (146)-/3 - 
glucan. KRE6 and SKN1 encode phosphorylated 
integral-membrane glycoproteins, with Kre6p likely 
localized within a Golgi subcompartment. Deletion of 
both these genes is shown to result in a dramatic dis- 
organization of cell wall ultrastructure. Consistent with 
their direct role in the assembly of this polymer, both 
Kre6p and Sknlp possess COOH-terminal domains 
with significant sequence similarity to two recently 
identified glucan-binding proteins. 
Deletion of the yeast protein kinase C homolog, 
PKC1, leads to a lysis defect (Levin, D. E., and E. 
Bartlett-Heubusch.  1992.  Mutants in the S.  cerevisiae 
PKC1 gene display a cell cycle-specific osmotic stabil- 
ity defect. J.  Cell Biol.  116:1221-1229).  Kre6p when 
even mildly overproduced, can suppress this pkcl lysis 
defect. When mutated, several KRE pathway genes and 
members of the PKCl-mediated MAP kinase pathway 
have synthetic lethal interactions as double mutants. 
These suppression and synthetic lethal interactions, as 
well as reduced/3-glucan and mannan levels in the 
pkcl null wall, support a role for the PKC1 pathway 
functioning in cell wall assembly. PKC1 potentially 
participates in cell wall assembly by regulating the 
synthesis of cell wall components, including 
(1--'6)-/3-glucan. 
B 
ut) growth in S. cerevisiae requires regulated cell wall 
synthesis (Cabib et al., 1982). Regulation of cell cycle 
events subsequent to START includes a coordinated 
regulation of cell wall biosynthetic genes responsible for new 
cell wall synthesis (Shaw et al., 1991) and polarization of the 
cytoskeleton  towards the site of cell wall growth (Adams and 
Pringle,  1984; Madden et al., 1992; Lew and Reed,  1993). 
Phosphorylation of biosynthetic components involved in cell 
wall synthesis represents a potential level of regulation that 
integrates the cell cycle with changes within the wall and en- 
suing morphological  events. 
PKC1 encodes a yeast homolog of the mammalian protein 
kinase C family (Levin et al., 1990). pkcl null cells possess 
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a G2-specific terminal lysis phenotype believed to be a con- 
sequence of  a fragile cell wall (Levin and Bartlett-Heubusch, 
1992). PKCl-deleted cells rapidly release their contents into 
the medium, and as judged by electron microscopy, possess 
thin cell walls which burst at the bud tip (Errede and Levin, 
1993).  The lysis phenotype of pkcl  can be partially pre- 
vented by the presence of osmotic-stabilizing  agents in the 
medium (Levin and Bartlett-Heubusch,  1992; Paravicini et 
al., 1992). PKC1 has been proposed to regulate cell wall syn- 
thesis through a bifurcated pathway comprising a MAP ki- 
nase cascade on one branch, and a second less well under- 
stood branch (Lee and  Levin,  1992; Errede and Levin, 
1993; Lee et al., 1993). PKC1 is though to act as an upstream 
regulator of this MAP kinase cascade, based on the isolation 
of dominant gain of function alleles of the MAP kinase ki- 
nase kinase, BCK1 (SLK1/SSP31), which suppress pkcl cell 
lysis (Lee and Levin, 1992; Irie et al., 1991; Costigan et al., 
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MAP kinase kinase homologs, are also able to suppresspkcl 
temperature-sensitive alleles from lysing (Ixie et al., 1993). 
Furthermore,  at elevated temperatures,  null mutations of 
all members of the MAP kinase cascade also exhibit an 
osmotic-suppressible lysis phenotype (Errede  and Levin, 
1993). MPKI(SLT2),  the MAP kinase at the base of  this path- 
way, has recently been isolated as a dosage-dependent sup- 
pressor ofa bckd null mutant (Lee et al., 1993) and indepen- 
dently isolated according to its cell lysis phenotype (Torres 
et al., 1991). MPK1 is suspected to phosphorylate a variety 
of substrates, including transcription factors, in a  manner 
analogous to the FUS3/KSSl-dependent activation of STE/2 
(Errede  and Levin,  1993).  Additional components of the 
PKCl-mediated MAP kinase cascade suppress pkd cell lysis 
when overproduced; these include PPZ/and PPZ2, a pair of 
serine/threonine phosphatases,  and BCK2,  a  gene of un- 
known function (Lee et al., 1993).  Despite the requirement 
for  PKC1 in  maintaining correct  cell  wall  ultrastructure 
(Paravicini et al., 1992),  its role in regulating cell wall syn- 
thesis remains unknown. 
Many genes involved in the assembly of cell wall compo- 
nents such as chitin, mannan, and fl-glucan have been iden- 
tiffed (for reviews see Bulawa,  1993;  Ballou,  1990;  Klis, 
1994).  However,  how genes involved in cell wall synthesis 
are  regulated,  is  poorly understood.  Among known cell 
wall-related genes are a number of K1 killer toxin resistant, 
or KRE genes, involved in the synthesis of the cell wall poly- 
mer (l~6)-/$-glucan  (Boone et al.,  1990;  Meaden et al., 
1990;  Bussey,  1991; Hill et al.,  1992;  Brown et al.,  1993; 
Brown and Bussey,  1993).  The cloned and characterized 
KRE genes, include two highly homologous genes, KRE6 
and SKN1 (Roemer and Bussey,  1991; Roemer et al., 1993). 
Disruption of KRE6 results in slow growth and killer resis- 
tance, presumably due to a 50% reduction in the wild-type 
level of cell wall (1--'6)-/$-glucan.  Loss of SKN1 has no effect 
on killer sensitivity, growth, or (l~6)-/~-glucan levels. SKN1 
is, however, a functional homolog of KRE6 and can suppress 
the kre6 null phenotypes in a dosage-dependent manner. De- 
letion of both KRE6 and SKN1 results in a severe growth de- 
fect which can be lethal in some strain backgrounds. The 
slow growth defect of viable kre6 sknl null deletion strains 
can be partially alleviated by the accumulation of spontane- 
ous extragenic suppressors. Such kre6 sknl null suppressed 
strains possess little, if any, (l~6)-/3-glucan. Because KRE6 
and SKN1 are required for the majority of this polymer, and 
since single disruptions of either gene lead to structurally 
wild-type (1-,6),~-glucan, KRE6 and SKN1 have been pro- 
posed to function independently and to act early in the as- 
sembly of the polymer, possibly as glucan synthases. 
The KRE6 and SKN1 gene products, Kre6p and Sknlp, 
have been characterized to  further examine their role  in 
(l~6)-/$-glucan assembly. Here, KRE6 and SKN1 are shown 
to encode phosphorylated integral-membrane glycoproteins 
that are likely localized to the Golgi apparatus. The topology 
implied by the posttranslational modifications of Kre6p and 
Sknlp, offers the potential for both proteins to link cytoplas- 
mic regulation with the secretory pathway-based assembly of 
the (l~6)-/$-glucan polymer. The observed phosphorylation 
of both  Kre6p  and  Sknlp  prompted  an  examination  for 
genetic interactions with suspected cell wall regulating ki- 
nases. KRE6-dependent suppression of the pkcl lysis defect, 
as well as synthetic lethal interactions between several KRE 
genes and members of the PKCl-mediated MAP kinase path- 
way, support the contention that a role of the PKC1 pathway 
is to act on cell wall assembly. 
Materials and Methods 
Yeast Strains, Media, and Methods 
Yeast strains used in this study are listed in Table I. Media for yeast growth 
and sporulation were as described in Guthrie and Fink (1991). YPD is yeast 
complex medium; YNB is a synthetic medium that was supplemented with 
appropriate nutrients. Low phosphate minimal medium was prepared ac- 
cording to Haguenauer-Tsapis and Hinnen (1984).  Yeast mating, sporula- 
tion, and tetrad analysis were performed as described in Guthrie and Fink 
(1991).  Resistance and  sensitivity to  K1  killer toxin was scored by the 
seeded plate assay of Bussey et al. (1982) and Hutchins et al. (1983).  Yeast 
transformations were by the lithium acetate method of lto et al. (1983) using 
100/~g of sheared, denatured carrier DNA (Schiesfl and Gietz,  1989). 
Cell Wall Analysis 
Analysis of the composition of the pkclA cell wall proved difficult due to 
its cell lysis phenotype. Osmotic-stabilizing agents, although required for 
pkclA cell growth, distort sample weights significantly and prevent polymer 
levels being normalized to dry weight of cells, pkclA cell lysis also pre- 
cluded the option of washing away the osmotic supplement before sample 
weighing. Normalizing cell wall polymer levels to the wet weight of cells 
is also likely to be inaccurate with such lyric strains. To attempt to overcome 
these problems, cell walls from the various strains were isolated, as de- 
scribed by Van Rinsun et al. (1991), and all cell wall polymer measurements 
were normalized per mg cell wall dry weight. The pkclA strain, GPYI115, 
was extremely sensitive to glass bead agitation; lysing completely after a 
few brief vortex pulses.  500-ml  cultures of GPYlll5  harboring either 
pRS315 or pRS315-KRE6 plasmids were grown to mid log in YNB sup- 
plemented with 0.5  M  KC1. Two  100-ml aliquots of each culture were 
processed to provide an accurate cell wall dry weight determination. Three 
100-ml aliquots of each culture were processed to determine/~-glucan lev- 
els. Alkali-insoluble (l'-"6)-t3-glucan and (l~3)-~-glucan were isolated af- 
ter NaOH  extractions according to Boone et al.  (1990).  Alkali-soluble 
(l~3)-/$-glucan levels were estimated from NaOH extraction supernatants 
by precipitating carbohydrates with two volumes of ethanol at -20°C. car- 
bohydrates were measured as hexose as described by Badin et al. (1953). 
Mannoprotein was isolated from 250-ml cultures of GPY1115 transformed 
with KRE6, PKC1, or control plasmids grown to mid log in 0.5 M KCl-sup- 
plemented YNB, according to Ballou (1990).  Mannan levels were deter- 
mined by measuring bexose, and normalized to the cell wall dry weight de- 
termined from an additional 100-mi of each culture. 
Electron Microscopy 
Tetrads from strains TR67 and TR160 were dissected to isolate fresh kre6A 
and skn/A haploid strains TR510 and TR511, respectively. TR512 is a con- 
genie wild-type spore progeny from TR67.  TR211  and TR213 are kre6A 
skn/A strains possessing independently  derived extragenic mutations which 
partially suppress their slow growth phenotype. 10-mi cultures of TR211, 
TR213, TR510,  TRSI1, and TRS12, were grown in YPD to a cell density 
of 107/ml and processed as described by Boone et al. (1990) with the single 
modification that samples were embedded in Epon. Sections were viewed 
on a Philips EM410 electron microscope at an opening voltage of 80 kV. 
TR211  and  TR213  cell  wall  ultrastructure  phenotypes  were  indistin- 
guishable. 
Plasmids 
Previously, YEp24-KRE6 was constructed as a 4.6-kb KRE6 BamHI-SalI 
fragment in the multicopy plasmid, YEp24 (Roemer and Bussey,  1991). 
This same KRF_,6 BamHI-SalI insert was subcloned into the centromeric 
plasmid, pRS315,  and named pRS315-KRE6 (Roemer and Bussey, 1991). 
YEpl3-KRE6 contains a 4.2-kb KRE6 BamHI/Dra I fragment inserted into 
the BamHI-PvuII sites of the 2 ttm-based plasmid, YEpl3. SKN1 was sub- 
cloned as a 5.5-kb SalI-HindIII fragment into the 2 ttm plasmid, YEp352, 
and named YEp352-SKN1  (Roemer et al., 1993).  YEpl3-PKC1 is a 4.3-kb 
PKC1 SphI fragment in YEp13. 
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Strain  Genotype  Source 
SEY6210 
TR92 
TR95 
TRI44 
TR178 
HAB806 
TR520 
TR67 
TR510 
TRS12 
TR160 
TRS11 
TR21 l 
TR213 
GPY1115 
MHD93 
3233-1B 
TRS00 
TR501 
TR502 
TR503 
TR504 
GPY100 
GPY102 
GPYI04 
LB3003-2Aa 
MAT ct 1eu2-3,112  ura3-52 his3-A200 lys2-80 trpl-Ago1  suc2-A9 
MAT a kre6::HIS3  1eu2-3,112  ura3-52  his3-A200 lys2-801  trpl-Ag01  suc2-A9 
MAT c~ kre6::HIS3 1eu2-3,112  ura3-52  his3-A200 lys2-801  trpl-A901  SUc2-A9 
MAT ct kre6::TnlO 1eu2-3,112  ura3-52 his3-A200 lys2-801  trpl-A901  suc2-A9 
MAT tx skn l : :LEU2 leu2-3,112  ura3-52 his3-A200 lys2-801  trp l-A 901  suc2-A9 
MAT ct krell::URA3  1eu2-3,112  ura3-52 his3-A200 lys2-801  trpl-A901  suc2-A9 
MAT (x kre2::TRP1  1eu2-3,112  ura3-52 his3-A200 lys2-801  trpl-A901  suc2-A9 
MATa/MATct KRE6/kre6: :HIS3 his3/his3  leu2/leu2/canl /cam 
kre6::HIS3 his3 leu2 canl 
his3 leu2 canl 
MAT a/MATc~ SKN1/sknl::LEU2  his3/his3  leu2/leu2  canl/canl 
sknl::LEU2 his3 leu2 cam 
kre6::HIS3 sknl::LEU2  his3 leu2 can1 
kre6::H1S3  sknl:: LEU2 his3 leu2 can1 
MAT a pkcl::HIS3  1eu2-3,112  ura3-52 his3-A200 trpl-Ag011  suc2-A9 ade2-101 
MA Ta slt2 : : URA3 ura3 1eu2-3,112  his3-A1  trp l 
MA Ta mkk  l : :  LE  U2 mkk2 : :HlS  3 ura3 leu2  his3 trp l 
MAT a/MATct KRE6/kre6: : Tnl O PKC1/pkcl : :HIS3 leu2-3,112/leu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A200  lys2-801/lys2-801  trp l-A901/trp l-Ag01  suc2-A9/suc2-A 9 ADE2/ade2-101 
MAT a/MATc~ SKN1/sknl :  :LEU2 PKC1/pkcl :  :HIS3 leu2-3,112/1eu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A200  lys2-801/lys2-801  trp l-AgO1/trp l-Ago1  suc2-A9/suc2-A9 ADE2/ade2-101 
MAT a/MATct KRE11/kre l l : :URA3 PKC1/pkc  l ::HIS3 leu2-3,112/leu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A200  lys2-801/lys2-801  trp l-AgO1/trp l-AgO1 suc2-A 9/suc2-A9 ADE2  /ade2-101 
MAT a/MATa KRE2/kre2::TRP1 PKC1/pkcl : :HIS3 leu2-3,112/1eu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A200  lys2-8Ol /lys2-801  trp l-Ago1/trp l-A901  suc2-A9/suc2-A9 ADE2/ade2-101 
MAT a/MATc~ KRE2/kre2::TRPI KRE6/kre6::HIS3 leu2-3,112/leu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A200  lys2-801/lys2-801  trp l-A901/trp l-AgOl  suc2-A9/suc2-A9 
MAT a/MATc~KRE6/kre6::HIS3 SLT2/slt2::URA3 leu2-3,12/leu2-3,112  ura3-52/ura3-52 
his3-A2OO/his3-A1  LYS2/lys2-801  trpl-A9Ol/trpl  SUC2/suc2-A9 
MAT a/MATtx KRE6/kre6: :URA3 MKK1/mkkl : :LEU2 MKK2/mkk2: :HIS3 leu2-3,112lieu2 
ura3-52/ura3  his3-A2OO/his3  LYS2/lys2-801  trp l-A901/trp l  SUC2/suc2-A9 
MAT a/MATa KRE11/kre l 1:  : URA3 MKK1/mkkl : :LEU2 MKK2/mkk2 :  :  HIS3 leu2-3 ,112lieu2 
ura3-52/ura3-52  his3-A2OO/his3  LYS2/lys2-801  trpl-AgOl/trpl  SUC2/suc2-A9 
MATa ura3 his4 mnn9 
S.  D. Emr 
Roemer and Bussey, 
1991 
Roemer and Bussey, 
1991 
Roemer and Bussey, 
1991 
Roemer et al.,  1993 
Brown et al.,  1993 
M.  Lussier 
Roemer and Bussey, 
1991 
This work 
This work 
Roemer et al.,  1993 
This work 
Roomer et al.,  1993 
Roemer et al.,  1993 
Paravicini et al., 
1992 
C.  Nombela 
K.  Matsumoto 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
T.  Stevens 
Epitope Tagging 
Standard molecular manipulations were as described by Sambrook et al. 
(1989).  Epitope tagging of Kre6p and Sknlp was performee as described 
by Kolodziej and Young (1991). The following complementary oligonucleo- 
tides encoding the influenza virus hemagglutinin (HA) l sequence in frame 
with SKN1 and KRE6 open reading frames were designee: SKN1 oligos 429 
(TACCCATACGACGTCCCAGACTACC.d2TTCTC~:~A) and  430  (GAA- 
GCGTAGTC~CGTCGTATGC~TAT)  and KRE6 oligos  598 (GAT- 
CTCAACTACAACCCATACGACGTCCCAGACTACGCT) and 599 (GAT- 
CAGCGTAGTC'IU)GGACGTCGTA~TTGTAGTTGA).  Oligos  429 
and 430 were annealed and subclonee into the corresponding PstI site of 
YEp352-SKN1.  Similarly,  oligos 598 and 599 were annealee and ligatee 
into the unique Bgl~I site of YEp24-KRE6  and pRS315-KRE6. Subclones 
possessing the epitope insertion could be identified by restriction mapping 
a unique AatII site (shown in bold) present in the oligonuclcotide  sequence. 
A  selection for positive subelones that possessed the oligonuclcotide  se- 
quence in the correct orientation, was facilitated by introducing an in-frame 
stop codon (shown underlined) to truncate the protein when the oligonucle- 
otides were ligatee in the incorrect orientation. Thus, transforming AatlI  + 
subciones into the kre6A strain, TR92, yielded two populations of transfor- 
1. Abbreviations used in thispaper:  BB, breakage buffer; HA, influenza vi- 
rus hemagglutinin; Kretp-HA, epitope-taggee  version of Kre6p; PAS, pro- 
tein A Sepharose; Sknlp-HA, epitope-taggee version of Sknlp; WB, wash 
buffer. 
mants; one of fast growing killer toxin sensitive transformants that harbor 
the correctly taggee construct, and a second population of slow growing 
killer toxin resistant transformants possessing AatII  + subclones whose oli- 
gonucleotides were ligated in the incorrect orientation. Functional epitope 
taggee versions of these plasmids were named YEp352-SKN1-HA, YEp24- 
KREt-HA, and pRS315-KREt-HA,  respectively. 
Cell Labeling and lmmunoprecipitations 
Cell labeling and immunoprecipitations were performee essentially as de- 
scribed by Cooper and Bussey  (1989).  10-ml cultures of 107 cells were 
grown up in appropriate minimal medium for 35S- or 32p-labelihg, har- 
vestee, concentrated fourfold, and grown an additional 30 min in fresh min- 
irnal medium. Cells were labeled with either 100 #Ci of Trans 35S-label or 
carrier-free [32p]orthophosphate  (ICN  Biocbemicals,  Irvine CA)  for  15 
rain with shaking.  Tunicamycin-treatee  cultures (10 /~g/ml) were prein- 
cubatee with the drug 30 min before labeling.  After labeling, cultures were 
pelleted by centrifugation, and washed with ice-cold breakage buffer (BB) 
(150 mM NaCI, 10 raM Na2 B407 [pH 8.0]). Cells were resuspendee in 65 
#1BB, supplemented with 1.5 #g/ml leupeptin, 3 ~,g/ml pepstatin A, 1 mM 
PMSF, and a 50-100-#1 vol of acid-washee  glass beads (0.45-0.5-mm pore 
diameter) was addee. (A pbosphatase inhibitor, 5 mM sodium molybdate, 
was also added in 32p-labeling experiments.) Samples  were left on ice for 
10 rain, and then vortexee strongly 15-20 times for 20 s intervals, with alter- 
nating short incubations on ice. Membrane proteins were solubilized  with 
the addition of 10 #t 10% SDS, and incubated for 5 rain at 95°C.  Samples 
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lected and diluted 10-fold in 1.0 ml reaction buffer (RB) (50 mM Tris-HCt 
pH 8.0, 150 mM NaC1, .1% Triton X-100, 1 mM EDTA, 2 m~/ml BSA, 1.5 
/~g/ml leupeptin, 3 #g/ml pepstatin A, 1 mM PMSF [including 5 mM so- 
dium molybdate in 32P-labeling experiments]).  Samples  were centrifuged 
again for I rain and supernatants transferred to fresh tubes. To diminish the 
nonspeeific  binding of radiolaboled  proteins, 100/~1 protein A-Sepharose 
(PAS) (CI-4B, Pharmacia LKB Biotechnology,  Piscataway, NJ) was added 
and samples were incubated at 40C for 1 h with rotation. Supernatants were 
collected and transferred to a fresh tube, to which a  1:150 dilution of the 
12CA5 monoclonal antibody (Berkeley  Ab Company, Berkeley,  CA) was 
added.  Samples were incubated with 12CA5 at 4°C with rotation for 2 h, 
and then immunopreeipitated after a  1-h incubation at 4°C with rotation, 
with the addition of 50/xl PAS. (To remove radiolabeled RNA from 3~p_ 
labeling experiments,  ~200/~g RNase A was added and incubated for an 
additional 30 rain at 4°C). After immunoprecipitations, samples were sub- 
jected to a brief centrifugation to pellet PAS beads.  Immunoprecipitates 
were washed four times in wash buffer (WB) (50 mM Tris-HCl pH 8.0, 150 
mM NaCI,  0.1% Triton-X-100),  and finally  suspended  in 50 td Laemmli 
loading buffer, boiled 5 min, and analyzed by SDS-PAGE. Fluorography  of 
35S-labeled samples  was  enhanced by  bathing gels  in a  1.0  M  sodium 
salicylate  solution before drying. 
Labeling and immunoprecipitation of Kre6p-HA in the pkcl null strain 
GPYIll5, as well as its isogenic  wild-type  parent strain, SEY6210, were 
carried out as described above, in low phosphate media supplemented with 
0.5 M KC1. Kre6p-HA protein levels were determined by Western analysis. 
Endo H Digestion 
Immune complexes bound to PAS were washed three times with WB, fol- 
lowed by two additional  washes in 1.0 ml of 100 mM sodium citrate (pH 
5.5). Samples were then resuspended in 200 ml sodium citrate buffer con- 
talning the above protease inhibitors, and digested with 10 mU Endo H (or 
mock digested)  overnight at 37°C.  Samples  were then washed twice with 
WB, and processed as described for 35S-labeled samples. 
Extraction of  Membrane Proteins 
Membrane association of both Kre6p and Sknlp was determined as de- 
scribed by Ljungdahl et al. (1992). Protein extracts from 50-ml cultures ex- 
pressing Kre6p-HA or Sknlp-HA were prepared by glass bead lysis,  and 
centrifuged at 1,000 g to remove nonlysed cells. Supernatants were removed 
and split into five separate 80-t~l fractions.  Four fractions were adjusted to 
a final concentration of either 0.1 M Na2CO3 (pH 11.0), 0.5% Triton X-100, 
1.6 M urea, or 0.6 M NaC1, in a final volume of 200 t~l. These samples were 
incubated 15  min on ice,  and fractionated by high speed centrifugation 
(150,000 g for 15 min at 4°C). A fifth sample was diluted to 200 ILl with 
BSB, and subjected to a low speed spin of 14,000 g for 10 min. The pellet 
and supernatant fractions for all samples were collected and solubilized in 
Laemmli buffer at 95°C before analysis by SDS-PAGE. Western blots were 
performed using a 1:2,000 dilution  of 12CA5 antibody, and 1:1,000 of horse- 
radish peroxidase-conjugated goat anti-mouse secondary antibody, and de- 
veloped  using  the  ECL  chemiluminescence detection  kit  (Amersham 
Canada, Oakville,  Ontario). 
Indirect Immunofluorescence Microscopy 
Exponentially  growing wild-type yeast strains harboring plasmids encoding 
either epitope-tagged  Kre6p-HA constructs, or native Kre6p were fixed 
with 3.7% formaldehyde,  and treated for immunofluorescence  microscopy 
using standard techniques (Pringle et al.,  1991). Antibody dilutions were 
1:3,000 and 1:1,000 for 12CA5 and Texas red-conjugated goat anti-mouse 
secondary antibody,  respectively.  Cells  expressing  epitope-tagged  Kre6p 
(Kre6p-HA) were viewed under Texas red excitation wavelengths to indicate 
the subeellular localization  of Kre6p,  and under 4',6-diamidino-2-pbenyl- 
indole (DAPI) excitation irradiation to visualize DNA.  Images  were ob- 
tained using a Zeiss Axioplan Microscope,  and represent '~ a 2,000-fold 
magnification. 
Homology Search 
Amino acid sequences of Kre6p and Sknlp were compared with all entries 
in GenBank non-redundant  protein sequence database Release 81 (February 
15,  1994) (Altschul  et al.,  1990).  Computer alignment was created using 
GENE WORKS (Intelligenetics,  Inc., Mountain View, CA). 
Results 
KRE6 and SKN1 Are Required  for Normal Cell 
Wall Ultrastructure 
To further explore phenotypes associated with the loss of the 
KRE6 and SKN1 genes, the cell wall ultrastructure of kre6A, 
sknlA, and kre6A sknlA strains  was examined by electron 
microscopy. A correlation was found between the loss of cell 
wall integrity  and the  severity of mutant phenotypes.. The 
kre6  null  strain  has  an  altered  cell  wall  ultrastructure 
reminiscent of that previously seen in both krel and kre9 null 
mutants  (Fig.  1)  (Boone et al.,  1990;  Brown and  Bussey, 
1993). The kre6 null cell wall lacks a darkly staining outer 
layer through  to be composed primarily  of rnannoproteins 
(Zlotnik et ai., 1984). The thick central layer of the cell wall, 
composed largely of B-glucan (Zlotnik et al.,  1984; Horis- 
berger and Clerk,  1987),  was also noticeably different in 
kre6 null cells, appearing more amorphous than  wild-type 
cell walls.  In contrast,  the strain  deleted for SKN1, which 
alone shows no pronounced cell wall phenotype, possessed 
a cell wall ultrastructure similar to that of the wild-type, kre6 
skn/null strains display a dramatic alteration in cell wall ul- 
trastructure,  lacking the darkly staining marmoprotein outer 
Figure L  Cell wall electron micrographs of kre6 and sknl mutants. 
(top left) Wild type (TR512);  (top right) sknlA  (TRSll);  (bottom 
left ) kre6A (TR510); and (bottom right) kre6A sknl A (TR213). The 
kre6 sknl double null mutant shows these defects despite having ac- 
quired extragenic mutations capable of improving growth of the 
original double null strain. Bar,  1.0/~m. 
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delaminated. 
Kre6p and Sknlp Share Homology with 
Glucan-binding  Proteins 
Kre6p and Sknlp share similarity to portions of the recently 
identified Rhodotherraus marinus (1-*3)-/~-glucanase,  bglA 
(Spilliaert, R., G. O. Hreggvidsson, J. K. Kristjansson, G. 
Eggertsson, and A. Palsdottir, unpublished results) and the 
(1-*3)-/~-glucan  dotting factor, FGA, from horseshoe crab 
(Seki et al., 1994) (Fig. 2). FGA shares similarity to 0-*3)- 
~-glucanases  throughout  its  amino  terminal domain  and 
binds (1-*3)-/~-glucan to initiate an immune response against 
invading fungi. The bglA and FGA proteins share significant 
homology within two 100-amino acid stretches of both the 
Kre6p  and  Sknlp  COOH-terminal  domains.  Kre6p  and 
Sknlp  also  share  similarity to  a  portion of the bacterial 
(1-*3)-/~-glucanase  active site amino acid sequence, Glu*- 
Ile-Asp-Ile-Glu; including its proposed active site catalytic 
nucleophile Glu* (Hoj et al.,  1992;  Planas et al.,  1992). 
Immunodetection of  Kre6p and Sknlp 
We sought to identify the KRE6 and SKN1 gene products, as 
an initial step in their characterization. Epitope-tagging of 
Kre6p and Sknlp was carried out by inserting a 9-amino acid 
segment of the HA protein (Kolodziej and Young, 1991) into 
the amino-terminal domain of each protein. Epitope-tagged 
versions of both Kre6p (Kre6p-HA) and Sknlp (Sknlp-HA) 
functioned as the wild-type gene products, as judged by both 
growth restoration and the ability to confer toxin sensitivity 
in the kre6A strain, TR92 (data not shown). 
Immunoprecipitations from whole cell extracts using anti- 
HA  monoclonal  antibody,  12CA5, specifically  detected 
Kre6p-HA  and  Sknlp-HA  proteins  (Fig.  3).  Kre6p  and 
Sknlp  are  predicted  to  encode  80-  and  85-kD  proteins, 
respectively. Their actual mobilities are substantially slower 
than predicted; in the apparent molecular mass range of 120 
kD for Kre6p-HA and 125-130  kD for Sknlp-HA. Interest- 
ingly, Sknlp-HA migrates as a doublet, with the major form 
migrating slightly slower than the minor species. Whether 
these two forms of Sknlp-HA are the resuk of proteolysis, 
or represent some other protein modifications has not been 
determined. 
Kre6p and Sknlp are quite acidic, with predicted pI's of  4.2 
and 4.4, respectively. As often reported for acidic proteins 
(Cooper et al., 1989),  their anomalous apparent molecular 
mass could partly be a reflection of reduced SDS binding and 
distortion of their charge/mass ratio. However,  Kre6p and 
Sknlp are also predicted to possess substantial cytoplasmic 
and lumenal domains accessible to a  variety of potential 
posttranslational modifications which may also contribute to 
their mobility on SDS-PAGE. 
Kre6p and Sknlp Are N-Glycoproteins 
Glycosylation  could contribute to the anomalous mobility of 
Kre6p and Sknlp. To examine this possibility, the mobilities 
of both Kre6p and Sknlp from both tunicamycin-treated and 
non-treated  cell  cultures  were  compared.  Tunicamycin- 
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bglA (39-286)  /~WE  L~S  DE  ~DY ~LP  D P  EKWD YD~-  G -  H ~GN  QE L~  .......  ~TRAR  I  ENARVGG  50 
FGA  (24-2931  I(~I~V  I  TA KR  E  D  Y DG  F  K - -[~K  RL~T Q F  D K  SW  KY~K I~AKMA  I~S F t~- J_  ~ .... %L~%~  97 
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Figure 2. Similarity of Kre6p 
and Sknlp to FGA and bglA. 
Residues conserved by at least 
one member of each pair of 
protein sequences are boxed. 
Homology  to  the  bacterial 
#-glucanase  active site  se- 
quence,  Glu-Ile-Asp-Ile-Glu, 
is  underlined.  An  asterisk 
identifies the proposed cata- 
lytic nucleophile (Hoj et al., 
1992;  Planas  et  al.,  1992). 
Gaps (---) have been  intro- 
duced to improve alignments. 
Accession numbers for FGA 
and  bglA are  D16622 and 
U04836, respectively. 
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TR92, expressing either Kre6p-HA or Sknlp-HA, was grown in the 
presence or absence of tunicamycin 30 min before 3sS-labeling, 
immunoprecipitated with 12CA5, and analyzed by SDS-PAGE  and 
fluorography. (B) Endo H treatment of Sknlp-HA immunoprecip- 
Rate. 
Figure 3.  Immunodetection of Kre6p-HA and Sknlp-HA.  Strain 
TR92, was transformed with epitope-tagged KRE6 or SKN1 plas- 
mids,  or  their  respective untagged  control  plasmids,  and  35S- 
labeled 10 min before immunoprecipitation with 12CA5 monoclo- 
nal antibody. Immunoprecipitates were analyzed by SDS-PAGE 
and fluorography. Relative molecular masses are shown to the left 
in kD. 
treated cell cultures expressing either Sknlp-HA or Kre6p- 
HA show a  10-kD increase in mobility relative to untreated 
control cultures (Fig. 4 A). Similar mobility shifts were de- 
tected  when  treating  immunoprecipitated  Sknlp-HA  or 
Kre6p-HA (data not shown) with the endoglycosidase, Endo 
H  (Fig. 4 B). 
Asparagine-linked glycoproteins contain a GlcNAc2Man9 
Glc3 core moiety that is attached and modified in the ER 
(Abeijon and Hirsehberg,  1992),  and often extended with 
outer chains later in the secretory pathway (Herscovics and 
Orlean, 1993). Strains possessing a mnn9 mutation are unable 
to elaborate N-linked core oligosaccharides (Ballou, 1990), 
and allow one to discern whether such outer chain modifica- 
tions occur in a given N-glycoprotein. Kre6p-HA and Sknlp- 
HA were expressed in the mnn9 strain LB3003-2Aa, and 
their electrophoretic mobilities compared to those in wild- 
type strain SEY6210 (data not shown). The absence of any 
detectable mobility shift in the mnn9 strain, compared with 
wild type, suggests that both Kre6p and Sknlp are exclusively 
core-glycosylated. As each asparagine-linked core oligosac- 
charide is composed of •  2.5-kD of carbohydrate and as no 
mnn9-dependent  core elaboration was detected, the 10-kD 
N-linked glycosylation mobility shift suggested that 4-5 core 
oligosaccharides are attached to both Kre6p and Sknlp. This 
number is  consistent with the 5  and  6  potential N-linked 
glycosylation sites within the respective COOH-termini of 
Kre6p and Sknlp. 
N-linked glycosylation does not appear to be solely re- 
sponsible for the slow mobility of Kre6p and Sknlp,  since 
both tunicamycin-treated species  continue to migrate  sig- 
nificantly more slowly than their protein sequences predict. 
Possible O-linked glycosylation was examined using a null 
mutation of KRE2 which encodes a mannosyltransferase re- 
quired for complete O-linked glycosylation (Hausler et al., 
1992;  Hill et al.,  1992).  Both Kre6p-HA and  Sknlp-HA 
were produced into the kre2A strain, TR520, and their mo- 
bilities compared with those in a wild-type strain, SEY6210. 
No  obvious KRE2-dependent mobility  shift was  detected 
(data not shown). 
Kre6p and Sknlp Are Integral Membrane Proteins 
Kre6p and Sknlp both possess a conserved stretch of 30 hy- 
drophobic amino acid residues predicted to adopt an alpha- 
helical  secondary  structure  capable  of spanning  a  mem- 
brane.  To examine possible membrane association,  TR92 
whole cell extracts containing Kre6p-HA or Sknlp-HA were 
treated with  0.1  M  Na2CO3 and  separated  by high  speed 
centrifugation into  supernatant  and  pellet fractions.  Both 
Kre6p-HA and  Sknlp-HA  fractionated exclusively to  the 
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lysates from strain TR92, expressing either Kre6p-HA or Sknlp- 
HA, were subjected to either a low speed spin (LSS), or incubated 
in 0.1 M Na2CO3, 0.5% Triton X-100, 1.6 M urea, or 0.6 M NaC1, 
as described in Materials and Methods. Cell lysates were then sepa- 
rated into pellet (P) and supernatant (S) fractions by high speed 
centrifugation, analyzed by Western blotting with  12CA5, and 
visualized by ECL fluorography. 
membrane pellet after high speed centrifugation (Fig.  5). 
Similar fractionation profiles for both proteins were seen 
using high salt (0.6 M NaCI) or denaturing conditions (1.6 M 
urea).  Conversely, detergent treatment using 0.5%  Triton 
X-100 solubilized the majority of Kre6p-HA and Sknlp-HA. 
Kre6p Appears Localized to the Golgi Apparatus 
Initial synthesis of (l~6)-~/-glucan has been proposed to oc- 
cur early in the secretory pathway based on the characteriza- 
tion of KRE5 (Meaden et al., 1990).  KRE5 lacks any detect- 
able (1---6)-/~-glucan when deleted, and encodes a secretory 
protein  possessing  the  COOH-terminal  amino  acid  se- 
quence, HDEL; a retention signal for soluble ER proteins 
(Pelham et al.,  1988).  As Krerp and Sknlp also define an 
early event in the polymer's synthesis, the localization of 
these secretory proteins was sought. Indirect immunofluo- 
rescence microscopy of TR92  maintaining a  2  /~m-based 
Kre6p-HA  construct  revealed a  punctate-staining pattern 
suggestive of Golgi localization in yeast (Fig. 6) (Preuss et 
al.,  1992;  Redding et  al.,  1991; Nothwehr et  al.,  1993; 
Cooper and Bussey, 1992).  A variability in both the number 
of stained punctate spots per cell and the number of ceils 
stained per field was found. Such variability in staining likely 
reflects variation in protein abundance; a phenomenon com- 
monly seen using 2  /zm-based  plasmids  (Redding et  al., 
1991). The specificity of the immunofluorescence signal to 
Kre6p-HA was demonstrated by the observation that identi- 
cal  strains transformed with the same 2  /zm-based Kre6p 
construct lacking the HA epitope and identically processed, 
failed to provide any immunofluorescence signal. 
Attempts  to localize Kre6p-HA  expressed  from a  cen- 
tromeric-based plasmid proved unsuccessful. Although over- 
expression can lead to  mislocalization, overexpression of 
secretory membrane proteins is not believed to result in a 
mislocalization to the Golgi; instead mislocalization to the 
vacuole, and some accumulation in the ER are documented 
(Roberts et al.,  1992;  Nothwehr et al.,  1993;  Cooper and 
Bussey,  1992).  Of over 1,100 Kre6p-HA cells giving a clear 
staining pattern, more than 1,000  showed strong punctate 
staining,  while  only  ~150  showed  strong  punctate  plus 
weaker perinuclear (ER) staining. Less than 1% of Kre6p- 
HA cells showed faint perinuclear staining only, and no cells 
had vacuolar or cell surface staining. These observations 
suggest that Kre6p resides within a Golgi compartment. 
Preliminary experiments using Sknlp-HA rule out a cell 
surface localization, where under identical conditions we de- 
tect an equivalently abundant HA-tagged KRE/protein (to 
be published elsewhere). We are, however, unable to distin- 
guish whether Sknlp-HA resides in an ER or Golgi intracel- 
lular location. 
Kretp and Sknlp Are Phosphorylated Proteins 
Both Kretp and Sknlp are predicted to possess substantial 
cytoplasmic domains that are amino-terminal to their trans- 
membrane domain (Harthann et al., 1989; Parks and Lamb, 
1991) and that are potential substrates for protein kinases. To 
examine possible phosphorylation of these proteins, TR92 
transformed with either Kre6p-HA or Sknlp-HA expressing 
plasmids, or an untagged control construct was grown in the 
presence  of  [32p]orthophosphate  and  immunoprecipitated 
(Fig. 7). Kre6p and Sknlp are both phosphorylated as shown 
by appropriately sized signals on SDS-PAGE that are absent 
from control samples.  32p-labeled Kre6p-HA and Skidp-HA 
were similarly detected in a mnn9 background and in tunica- 
mycin-treated cell cultures, indicating that the phosphoryla- 
tion of Kre6p and Sknlp is due neither to phosphodiester 
linkages in N-linked outer chains nor to phosphorylation of 
N-linked core oligosaccharides (data not shown). Instead, 
Kre6p and Sknlp are phosphorylated on either serine/threo- 
nine or tyrosine residue(s). Consistent with this, phosphatase 
digestions removed radiolabel  from 32p-labeled Kre6p-HA 
and  Sknlp-HA  immunoprecipitates,  and  enhanced  their 
electrophoretic mobility slightly when these proteins were 
35S-labeled  (data  not  shown).  As  both  proteins  contain 
NH:-terminal domains composed of 21%  serine and threo- 
nine residues,  several  different phosphorylation site con- 
sensus sequences are evident; including those of PKC1, MAP 
kinase, cAMP-dependent protein kinase, and casein kinase 
(Kemp and Pearson,  1990). 
KRE6 Suppresses the Lysis Phenotype of  pkcl, 
but Not Defects in the MAP Kinase Branch of the 
PKC1 Pathway 
Recent  work  has  implicated  the  yeast PKC1 pathway in 
regulating cell wall growth (Levin and Bartlett-Heubusch, 
1992; Paravicini et al., 1992).  Disruption of PKC1 results in 
a lysis phenotype, which can be prevented by the addition of 
osmotic  support  to  the  medium  (Levin  and  Bartlett- 
Heubusch, 1992; Paravicini et al., 1992). As both Kre6p and 
Sknlp are phosphoproteins required for cell wall synthesis, 
possible genetic interactions between the KRE6, SKN/, and 
PKC1 were examined. Both centromeric and 2  /zm-based 
KRE6-containing  plasmids  transformed  into  the  pkclA 
strain, GPY1115, are capable of alleviating the pkcl osmotic 
lysis lethality when grown on YPD (Fig. 8). No significant 
difference in the level of Kretp-HA phosphorylation, how- 
ever,  was detected in the pkclA background vs wild type 
Roemer et al. Yeast  Glucan Biosynthetic Components  Kretp and Sknlp  573 Figure 6. Indirect immunofluorescence  of  Kre6p-HA. Strain TR92, possessing  either YEp24-KRE6-HA  or untagged  plasmid YEp24-KRF_,6, 
was prepared for immunofluorescence  as described in Materials and Methods. (left column) Kre6p-HA staining observed with 12CA5 
antibodies (Anti-HA); (center column) DAPI staining of nuclei and mitochondria; and (right column) cells viewed by Nomarski optics. 
(data not shown).  Overexpression of SKN1, failed to sup- 
press  the pkc/  null  lethality on  non-osmotically supple- 
mented media (data not shown). PKC1, when overexpressed 
from  a  multicopy  construct,  did  not  suppress  the  slow 
growth phenotype or killer resistance of a kre6 null mutation 
(data not shown). 
As KRE6 is  one of several KRE genes participating in 
(1--'6)-/5-glucan synthesis, additional KRE genes were tested 
for their ability to suppress thepkcl lysis phenotype. KRE/1, 
encoding a candidate regulatory component localized to the 
cytoplasm (Brown et al., 1993; Brown, J., personal commu- 
nication), as well as KRE/ and KRE9,  encoding secretory 
proteins involved in (l'~'6)-/3-glucan  assembly (Boone et al., 
1991; Brown and Bussey, 1993), were all incapable of rescu- 
ing pkcl lethality on YPD (data not shown). 
The PKC1 pathway is  thought to be branched,  and we 
asked whether KRE6 could suppress defects in the MAP ki- 
nase branch of  the PKCl-mediated pathway. Centromeric and 
2/zm-based KRE6  plasmids were transformed into mpk./, and 
nddd,2, null strains, and examined for growth at 37°C in the 
absence of osmotic-stabilizing supplements.  Neither mpk/ 
nor  ink/c/,2  null  strains  were  rescued  from  their  tem- 
perature-sensitive  lysis phenotype on  YPD  by additional 
copies of KRE6 (data not shown). 
Synthetic Lethal Interactions between 
KRE6 and Components of the PKCl-mediated MAP 
Kinase Cascade 
To investigate possible additional genetic interactions be- 
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Scored tetrads:~ 
G-enotype  Class*  PD  NPD  TT 
kre6A pkclA  SL  3  4  20 
sknl A pkcl A  N  3  2  9 
krel 1A pkclA  SL  4  4  7 
kre2A pkclA  SL  2  1  12 
kre6A mpkl (slt2)A  SL  1  2  8 
kretA mkklA mkk2A  SL  ND§  ND  ND 
krellA mkklA mkk2A  SL  ND  ND  ND 
kre6A kre2A  N  2  2  9 
* Classification of the double mutants at 300C on osmotically supplemented 
medium. N, normal growth; SL, synthetic lethal. 
PD, parental ditype; NPD, nonparental ditype; /7,  tetratype. Synthetic 
lethal spore progeny were inferred by scoring markers from viable progeny. 
§ ND, not determined. 
Figure  7.  Kre6p-HA and  Sknlp-HA  are phosphorylated.  Strain 
TR92, possessing either YEp24-KRE6-HA or YEp352-SKN1-HA, 
was grown  in low phosphate  medium and  labeled  with  [3zp]or- 
thophosphate before immunoprecipitation. TR92, maintaining the 
untagged plasmid, YEp24-KRE6, was similarly treated. Immuno- 
precipitates were analyzed by SDS-PAGE and fluorography. 
tween kre6A and pkclA, the kre6A pkclA double heterozy- 
gote TR500,  was sporulated and dissected onto osmotically 
supplemented YPD medium.  Tetrad analysis of spore prog- 
eny indicated that the pkcl kre6 double mutant spores were 
inviable, either on sorbitol or KCl-supplemented YPD plates 
(Table ID. The pkcl kre6 null spores germinated but invari- 
ably arrested with a small- to medium-sized bud. Additional 
synthetic  lethal  interactions  were  found  between kre6 and 
both mpkl and m/dr,2 double nulls at 30°C, which were also 
not rescued by osmotic supplements  (Table II). 
Synthetic Lethal Interactions between PKC1 and Other 
Cell Wall-related Genes 
To address  if synthetic  lethality  between pkcl  and kre6 is 
due  specifically  to  an  exaggerated  (l~6)-/3-glucan  defect, 
or whether other cell wall perturbations in combination with 
pkcl  can  also cause lethality,  genetic  interactions  between 
PKC1  and  other  cell  wall-related  genes  were  examined. 
KRE/1-deleted  strains possess a  (l~6)-/3-glucan  phenotype 
comparable to kre6 null strains (Brown et al.,  1993).  Tetrad 
dissection  of  the  pkcl  kre11 double  heterozygote  diploid 
strain,  TR502,  revealed pkcl kre11 spores to be inviable on 
1.2 M sorbitol-supplemented YPD (Table II). pkcl kre11 seg- 
regants invariably died after 2-5 cell divisions. A null muta- 
tion  in  KRE2,  a  marmosyltransferase  required  for correct 
O-linked  glycosylation  of marmoproteins  (Hausler  et  al., 
1992; Hill et al., 1992), also conferred a synthetic lethal phe- 
notype in combination with pkcl on sorbitol-supplemented 
YPD.  In contrast, skn/mutants  which lack any obvious cell 
wall phenotype fail to show an exaggerated growth defect in 
combination  with pkcl  (Table  II).  In addition,  combining 
kre6 and kre2 mutations lacked any synergistic growth defect 
(Table II). 
Figure 8.  Suppression of the 
pkclA  defect by  KRE6.  The 
pkclA  strain  GPYlll5,  was 
transformed with plasmids in 
the  presence  of 0.5  M  KC1. 
Transformants  were  streaked 
onto (A) a YPD plate supple- 
rnented with 0.5  M  KCI, and 
(B)  a  standard  YPD  plate. 
GPYIlI5  bears  (clockwise 
from  the  top)  2  /tin  plas- 
mid  YEpI3,  CEN  plasmid 
pRS315-KRF~ YEpl 3-KRE6, 
and YEpl 3-PKt~. 
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Strain*  Plasmid  (1 ~6)-B-Glucan 
Alkali-insoluble* 
(1--*'6) +  (1-'3)-B-Glucan 
Alkali-soluble* 
(l-"3)-/~-Glucan 
SEY6210  None  117.0  ±  4.7 
GPYlll5  pRS315  67.2  +  1.9 
GPY1115  pRS315-KRE6 TFI§  67.1  ±  1.7 
GPYllI5  pRS315-KRE6 TF2  72.8  ±  3.5 
GPY1115  pRS315-KRE6-HAII  74.9  ±  5.0 
657.2  +  10.1  380 
521.4  +  28.8  225 
468.0  +  3.0  208 
566.0  ±  2.8  239 
497.0  ±  23.0  199 
* Concentration  ~g/mg cell wall dry wt). 
* GPYIlI5 is a pkclA derived from the wild-type SEY6210. 
§ TF1  and TF2;  independent  transformants. 
II Centromeric-based epitope tagged KRE6 construct. 
Error represents 1 SD. 
pkcl A Cells Have an Altered Cell Wall 
Growth  in osmotic-supplemented media does not result  in 
substantial  changes to the cell wall of pkcl null cells since 
transfer to a low osmoticum after growth in osmotic-supple- 
mented conditions  leads to immediate pkcl cell lysis (Para- 
vicini et al., 1992). To examine the composition ofthepkcl 
null cell walls, GPYlll5 and the isogenic wild-type strain 
SEY6210 were grown in the presence of osmotic support, 
and their cell walls purified.  Fractionation  and quantitation 
of the various cell wall components revealed thatpkclA cells 
lack a  significant  amount of all  /3-glucan polymers when 
compared with wild type (Table Ill A). These results, show- 
ing an overall reduction of 30% in total B-glucan in a pkcl 
mutant,  are very similar  to those reported recently by Shi- 
mizu et al.  (1994).  Mannan,  the other major wall compo- 
nent,  was modestly reduced by 20%  in  this pkcl-deleted 
background (Table In B). 
To  address  whether  KRE6 suppression occurs through 
possible remodeling  of the pkcl cell wall, GPYlll5 strains 
harboring  a variety of KRE6 or control plasmids were grown 
in 0.5 M KCl-supplemented  media and their cell wall poly- 
mer levels compared.  No significant  increase in (1-*6)-B- 
glucan,  (1-*3)-B-glucan,  or mannan were seen in GPYlll5 
transformed with KRE6 (Table III, A and B). Thus, although 
the cell wall of GPYlll5 is very different from wild type, 
possessing reduced levels in all/3-glucan polymers and man- 
nan, the partial KRE6 suppression  of the pkcl osmotic lysis 
phenotype is not accompanied by an obvious restructuring 
of the wall. 
Discussion 
Our study addresses a number of new issues in the synthesis 
and  regulation  of an  extracellular  matrix  polymer in  S. 
cerevisiae. Previous work indicates that Kre6p and Sknlp are 
candidates  for/3-glucan biosynthetic enzymes (Roemer and 
Bussey, 1991; Roemer et al.,  1993). The/3-glucan and cell 
wall ultrastructural  effects seen in kre6 sknl mutants, and the 
sequence similarity  of regions of Kre6p/Sknlp to/3-glucan- 
binding domains of other proteins,  support this contention. 
The  Golgi  localization  of Kre6p  is  consistent with,  and 
extends,  previous work suggesting  a  sequential  secretory 
pathway-based synthesis of (1-*6)-B-glucan beginning in the 
ER, continuing within the Golgi, and being completed at the 
cell surface (Boone et al., 1990; Meaden et al., 1990). The 
relative frequency of Kre6p staining patterns in secretory or- 
ganelles is inconsistent with an alternative interpretation  that 
Kre6p is normally localized to the ER, but is mislocalized 
to the Golgi once the ER is saturated.  Epistatic relationships 
between KRE6 and KRE5 and KRE6 and KRE/(Boone et al., 
1990; Meaden et al., 1990) are consistent with a Golgi local- 
ization of Kre6p; with Kre6p acting downstream of a KRES- 
dependent  ER  event,  and  being  epistatic  to  the  KRE/- 
dependent cell surface event. A secretory pathway location 
for (1-*6)-B-glucan  synthesis  is also supported by work of 
Horisberger  and  Clerc  (1987)  who  have  shown  by  im- 
munogold labeling of (1-*6)-fl-glucan, that both intracellular 
and cell wall staining are observed. (1-*6)-B-glucan assem- 
bly in yeast likely parallels  extracellular  matrix polysaccha- 
ride synthesis in higher plants,  where for example xyloglu- 
can and pectin are synthesized within the secretory pathway 
and deposited within  the cell wall  (Moore and Staehelin, 
1988;  Zhang  and  Staehelin,  1992;  Levy and  Staehelin, 
1992; Driouich et al.,  1993; Gigeaut  and Carpita,  1993). 
A body of  biochemical evidence suggests that at least some 
(1-*6)-/~-l>glucan occurs as a glucosyl moiety on glycopro- 
teins (Van Rinsum et al., 1991; Klis,  1994) and the/3-gluco- 
sylasparagine  linkage  has recently been found on laminin 
(Schreiner  et al., 1994). Our work identifying genes whose 
products act to assemble this glucan polymer, could well be 
explained  by a set of components involved in such protein 
glucosylation.  This view of (1-*6)-/3-glucan biosynthesis as 
a newly described form of protein glycosylation would place 
the polymer in a conventional biochemical context. In yeast, 
both N- and O-mannosylation  of proteins are paradigm ex- 
amples of glycans synthesized  sequentially  in the secretory 
pathway, and subsequently secreted and assembled into the 
cell wall (Kukuruzinska  et al.,  1987). 
Demonstration of Kre6p and Sknlp as membrane proteins 
with both phosphorylation and N-glycosyl modifications,  in- 
dicates that these proteins possess both cytoplasmic and lu- 
menal domains.  Consistent with a type II membrane topol- 
ogy  for  Kre6p  and  Sknlp,  where  their  COOH-terminal 
domains would be lumenal,  the COOH-termini of both pro- 
teins possesses substantial homology with a pair of secreted/ 
extracellular  glucan-binding  proteins.  Such a type II topol- 
ogy has the potential to allow Kre6p and Sknlp to couple cy- 
toplasmic and lumenal  secretory processes to effect (1-*6)- 
B-glucan synthesis. 
We have  examined  the relationship  between KRE6 and 
SKN/and other KRE genes, with kinases implicated  in the 
regulation  of cell wall  synthesis.  Genetic interactions  be- 
tween KRE2, KRE6, KREll, SKN1, and PKC1 support the 
contention thatpkcl cells lyse as a result of a fragile cell wall. 
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PKC1  Transformants 
Mannan 
Strain  Plasmid  Ozg/mg cell wall dry wt) 
GPYl115  pRS315  386.6  +  29.8* 
GPY1115  YEpl3  377.7  +  23.9 
GPYlll5  pRS315-KRE6  444.2  +  55.2 
GPY1115  YEpl3-KRE6  421.7  +  36.0 
GPYlll5  YEpl3-PKC1  518.6  +  11.0 
* Error represents 1 SD. 
The basis of synthetic lethality for the kre6 pkcl and krell 
pkcl double mutants is not known, but is consistent with a 
further weakening ofthepkcl cell wall, presumably by exag- 
gerating  the  (l~6)-/~-glucan  defect.  Colethality between 
kre2 and pkcl suggests that the reduced synthesis of O-man- 
nosyl moieties of glycoproteins exacerbates the pkcl cell wall 
defect. Moreover, as mutants with defects in either the KRE2 
or KRE/1 genes alone grow quite well, their synthetic lethal- 
ity with a defective PKC1 underscores the fragile nature of 
the pkcl cell wall. Osmotic stabilizers are insufficient to res- 
cue these  synthetically lethal combinations,  probably be- 
cause the biosynthesis of wall components has been too se- 
verely affected. 
Expression of KRE6 from a centromeric plasmid is suf- 
ficient to partially suppress the osmotic lysis phenotype of 
a pkcl  null mutant. Of the cell wall-related genes tested, 
only KRE6  has this ability; other participants in the (1--~6)-/3  - 
glucan synthetic pathway, including Sknlp, cannot suppress 
the pkd lysis phenotype when overexpressed. Despite this 
evidence of a special role for KRE6, we have no direct evi- 
dence that Kre6p acts as a glucan synthase component in the 
suppression. KRE6 transformants in the pkcl strain showed 
no obvious increase in (1--'6)-/~-glucan,  or other cell wall 
polymer. The possibility remains, however,  that a  modest 
(1--'6)-/~-glucan or other cell wall alteration does occur with 
additional copies of KRE6,  and that this does improve the 
condition of  the cell wall, but that this alteration is below our 
relatively crude levels of detection. 
A number of lines of evidence strongly indicate that PKC1 
affects multiple cell wall synthetic events, and does not act 
on (1--"6)-/3-glucan synthesis alone. We have shown the pkcl 
null mutant lacks a significant amount of all cell wall/~-glu- 
can polymers, as well as mannan. This reduction in wall 
mass likely reflects the thinner, more fragile nature of the 
pkcl wall. pkclA cells also lack the characteristic cell wall 
ultrastructure evident in krel, kre6 and kre9-deleted  strains, 
and are osmotically fragile, unlike kre mutants. In addition, 
suppression of pkcl defects by KRE6 is only partial. 
PKC1 is thought to act through a MAP kinase cascade sus- 
pected of regulating multiple functions, and a  second un- 
known regulatory branch. KRE6 suppression of pkcl does 
not act primarily downstream of this MAP kinase branch of 
the PKC1 pathway, since KRE6 does not suppress the condi- 
tional lysis phenotype of mpkl(slt2) or mkk/,2 null strains. 
We have not, however, ruled out the possibility that the MAP 
kinase pathway partially regulates KRE6 expression. 
Is there a relationship between the KRE6 homolog, SKN1, 
and PKCI?. The lack of either colethality or suppression of 
pkcl by SKN1 could indicate a direct activation of Sknlp by 
Pkclp, such that in the absence of Pkclp, Sknlp is completely 
inactivated. Alternatively, there may be no relationship be- 
tween SKN1 and PKC1, and the absence of any genetic inter- 
action simply reflects the minor role SKN/plays relative to 
KRE6 during vegetative growth. 
Our results suggest two plausible relationships between 
PKC1 and KRE6 in (1--~6)-/3-glucan assembly. One model 
(See Fig. 9 A) is that KRE6 and the (1--'6)-/~-glucan pathway 
function in a manner that is independent of the PKC1 path- 
A  B 
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I  PKC1 klmme I 
,l 
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I  I  I 
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Regulation via Km6p 
PhosphoryIMion 
I  PKC1 kinase I 
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Cell Wall Assembly 
Figure 9.  Models for the in- 
teractions between the KRE6/ 
(1---6)-/~-glucan pathway, and 
the PKC1 pathway. See Dis- 
cussion for details. 
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a  common  process.  (l~6)-/~-glucan  synthesis  would  be 
viewed  as a parallel  cell  wall  assembly pathway to those 
regulated by PKC1. The in vivo level of all cell wall polymer 
classes, including  (1--'6)-/~-glucan,  appear reduced in pkcl 
strains, and further diminution of (1--'6)-/~-glucan levels by 
loss of Kre6p  would be lethal.  In this  model, another,  as 
yet  unknown,  protein  kinase(s)  would  regulate  (1--'6)-/~- 
glucan synthesis  through phosphorylation of Kre6p and/or 
Sknlp. PKC1 could function in such "global" cell wall regula- 
tion directly  or could indirectly  perturb these events  in a 
pleiotropic  manner, for example by disrupting cytoskeletal 
organization (Mazzoni et al., 1993). Very recently pkcl mu- 
tants have been shown to overproduce an extraceUular/~-glu- 
canase (Shimizu et al.,  1994) which may contribute to their 
loss of osmotic integrity. Overproduction of Kre6p a putative 
glucan synthase may have the capacity to make more glucan 
and to partially ameliorate the deleterious effects of the over- 
produced glucanase, resulting in partial in vivo suppression 
of the pkcl mutant phenotype. 
A  second possibility,  for  which  we  have  no  direct  ex- 
perimental support, is that (1--'6)-/3-glucan synthesis is regu- 
lated directly, or indirectly, by PKCl-dependent phosphory- 
lation of Kre6p through the less defined second branch of the 
PKC1 bifurcated pathway (See Fig. 9 B).  Protein kinase  C 
phosphorylation  of membrane  proteins  occurs  in  mam- 
malian ceils (Hunter et al., 1984; Li et al., 1993). Although 
the yeast PKC1 phosphorylation  consensus sequence is not 
known,  Kre6p  does  possess  several  RXXS/T  sequences 
(where  X  symbolizes  any  amino  acid  and  S/T  is  phos- 
phorylated)  found in the in vivo Pkclp pseudosubstrate  se- 
quence (Antonsson et al.,  1994;  Watanabe et al.,  1994). 
Kre6p could act downstream of Pkclp,  within or under the 
ill-defined  second branch of the PKC1 pathway, since Kre6p 
does not suppress mpkl(slt2) or mkk/,2 null mutations of the 
MAP  kinase  branch.  To explain  the kre6 pkcl  synthetic 
lethality, Kre6p must normally possess some residual activ- 
ity in a pkclA strain.  Synthetic  lethality  between kre6 and 
mkkl,2 or mpkl(slt2)  is consistent with creating lesions in 
both branches of the PKC1 pathway. Suppression ofpkcl by 
additional copies of KRE6 may occur by elevating the resid- 
ual activity  of Kre6p  enough to compensate for the non- 
stimulated form of Kre6p in apkd background. A prediction 
from this model is that Kre6p phosphorylation is dependent 
on PKC1. However,  Kre6p  remains  phosphorylated  in  a 
pkcl null background, indicating that a non-PKCl-dependent 
phosphorylation  of Kre6p must also exist. Confirmation of 
this model would require identifying  the Kre6p phosphory- 
lated residue(s) and demonstrating distinct in vivo phosphor- 
ylation patterns of Kre6p in a pkcl background vs wild type. 
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